SA is banking on its research expertise to gain a place at the international negotiating table for coronavirus vaccines. Unlike the US and UK, which have secured early access to millions of doses of experimental Covid-19 vaccines, SA lacks the financial muscle to pre-purchase stocks. Worse still, it has no capacity to make its own.

Scientists have moved at an unprecedented pace to develop a Covid-19 vaccine since the genetic sequence of the Sars-Cov-2 virus was published in January, as a safe and effective shot offers governments around the world the best hope of stemming the pandemic’s devastating health and economic costs. More than 170 potential vaccines are being tracked by the World Health Organisation, 29 of which are being tested on human volunteers...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.